Autoimmune features in metabolic liver disease: A single-center experience and review of the literature

Clinical Reviews in Allergy and Immunology

Volumn 45, Issue 1, 2013, Pages 143-148

  Tsuneyama, Koichi ^a   Baba, Hayato ^a   Kikuchi, Kentaro ^b   Nishida, Takeshi ^a   Nomoto, Kazuhiro ^a   Hayashi, Shinichi ^a   Miwa, Shigeharu ^a   Nakajima, Takahiko ^a   Nakanishi, Yuko ^a   Masuda, Shinji ^c   Terada, Mitsuhiro ^c   Imura, Johji ^a   Selmi, Carlo ^d,e  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c Kouseiren Takaoka Hospital   (Japan)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Female sex; Metabolic syndrome; Non alcoholic fatty liver disease

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; GLUTAMATE SODIUM; INTERLEUKIN 6; MITOCHONDRION ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CHOLANGITIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; HISTOLOGY; HUMAN; INFLAMMATORY INFILTRATE; LIVER CELL CARCINOMA; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIMARY BILIARY CIRRHOSIS; REVIEW;

ADULT; AGE FACTORS; AGED; ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; JAPAN; LIVER CIRRHOSIS, BILIARY; MALE; MICE; MIDDLE AGED; SEX FACTORS;

EID: 84880775381     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-013-8383-x     Document Type: Review

References (63)

1. Selmi C, Mackay IR, Gershwin ME (2007) The immunological milieu of the liver. Semin Liver Dis 27:129-139
2. Williams CD, Stengel J, Asike MI et al (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124-131
3. Liberal R, Grant CR, Mieli-Vergani G, Vergani D (2013) Autoimmune hepatitis: a comprehensive review. J Autoimmun 41:126-139
4. Selmi C, Bowlus CL, Gershwin ME, Coppel RL (2011) Primary biliary cirrhosis. Lancet 377:1600-1609
5. Selmi C, Invernizzi P, Keeffe EB et al (2004) Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol 38:264-271
6. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E (2011) Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54:374-385
7. Miyakawa H, Kikuchi K, Jong-Hon K et al (2001) High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis. J Gastroenterol 36:33-38
8. Miyakawa H, Kitazawa E, Fujikawa H et al (2000) Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOADC-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent anti-mitochondrial antibody. Hepatol Res Off J Jpn Soc Hepatol 18:1-9
9. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298-310
10. Mahady SE, George J (2012) Management of nonalcoholic steatohepatitis: an evidence-based approach. Clin Liver Dis 16:631-645
11. Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321
12. Nakanishi Y, Tsuneyama K, Fujimoto M et al (2008) Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 30:42-50
13. Sasaki Y, Shimada T, Iizuka S et al (2011) Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. Eur J Pharmacol 662:1-8
14. Sasaki Y, Suzuki W, Shimada T et al (2009) Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice. Life Sci 85:490-498
15. Kawaratani H, Tsujimoto T, Kitazawa T et al (2008) Innate immune reactivity of the liver in rats fed a choline-deficient l-amino-acid-defined diet. World J Gastroenterol WJG 14:6655-6661
16. Sakaida I, Okita K (2005) The role of oxidative stress in NASH and fatty liver model. Hepatol Res Off J Jpn Soc Hepatol 33:128-131
17. Nishida T, Tsuneyama K, Fujimoto M et al (2013) Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. Laboratory investigation. J Tech Methods Pathol 93:230-241
18. Lidar M, Lipschitz N, Agmon-Levin N et al (2012) Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia. Clin Rev Allergy Immunol 42:238-246
19. Agmon-Levin N, Ram M, Barzilai O et al (2009) Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun 32:261-266
20. Keppeke GD, Nunes E, Ferraz ML et al (2012) Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-alpha. PLoS One 7:e45392
21. Fischer S, Agmon-Levin N, Shapira Y et al (2013) Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis. Immunol Res 56:287-292
22. Shapira Y, Poratkatz BS, Gilburd B et al (2012) Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. Clin Rev Allergy Immunol 42:154-163
23. Wakabayashi K, Lian ZX, Leung PS et al (2008) Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 48:531-540
24. Wakabayashi K, Lian ZX, Moritoki Y et al (2006) IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 44:1240-1249
25. Wakabayashi K, Yoshida K, Leung PS et al (2009) Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin Exp Immunol 155:577-586
26. Tsuneyama K, Moritoki Y, Kikuchi K, Nakanuma Y (2012) Pathological features of new animal models for primary biliary cirrhosis. Int J Hepatol 2012:403954
27. Yang GX, Lian ZX, Chuang YH et al (2008) Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 47:1974-1982
28. Zhang W, Sharma R, Ju ST et al (2009) Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 49:545-552
29. Shoenfeld Y, Tincani A, Gershwin ME (2012) Sex gender and autoimmunity. J Autoimmun 38:J71-J73
30. Sawalha AH, Wang L, Nadig A et al (2012) Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J Autoimmun 38:J216-J222
31. Pennell LM, Galligan CL, Fish EN (2012) Sex affects immunity. J Autoimmun 38:J282-J291
32. Amur S, Parekh A, Mummaneni P (2012) Sex differences and genomics in autoimmune diseases. J Autoimmun 38:J254-J265
33. Selmi C, Tsuneyama K (2010) Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 9:A267-A270
34. Markle JG, Frank DN, Mortin-Toth S et al (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339:1084-1088
35. Atarashi K, Honda K (2011) Microbiota in autoimmunity and tolerance. Curr Opin Immunol 23:761-768
36. Lathrop SK, Bloom SM, Rao SM et al (2011) Peripheral education of the immune system by colonic commensal microbiota. Nature 478:250-254
37. Fasano A (2012) Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol 42:71-78
38. Lee TP, Chiang BL (2012) Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev 11:A422-A429
39. Miyashita T, Toyoda Y, Tsuneyama K, Fukami T, Nakajima M, Yokoi T (2012) Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models. J Toxicol Sci 37:931-942
40. Toyoda Y, Miyashita T, Endo S et al (2011) Estradiol and progesterone modulate halothane-induced liver injury in mice. Toxicol Lett 204:17-24
41. Yoshikawa Y, Miyashita T, Higuchi S et al (2012) Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries. Toxicol Appl Pharmacol 264:42-50
42. Selmi C, Brunetta E, Raimondo MG, Meroni PL (2012) The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 11:A531-A537
43. Pollard KM (2012) Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun 38:J177-J186
44. Carp HJ, Selmi C, Shoenfeld Y (2012) The autoimmune bases of infertility and pregnancy loss. J Autoimmun 38:J266-J274
45. Fujisaka S, Usui I, Ikutani M et al (2013) Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1alpha-dependent and HIF-1alpha-independent manner in obese mice. Diabetologia 56:1403-1412
46. Smorlesi A, Frontini A, Giordano A, Cinti S (2012) The adipose organ: white-brown adipocyte plasticity and metabolic inflammation. Obes Rev Off J Int Assoc Stud Obes 13(SUPPL. 2):83-96
47. Potenza MV, Mechanick JI (2009) The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract Off Publ Am Soc Parenter Enteral Nutr 24:560-577
48. Fujii H, Ikura Y, Arimoto J et al (2009) Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. J Atheroscler Thromb 16:893-901
49. Mitsuyoshi H, Yasui K, Harano Y et al (2009) Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol Res Off J Jpn Soc Hepatol 39:366-373
50. Salunga TL, Cui ZG, Shimoda S et al (2007) Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 29:78-86
51. Tsuneyama K, Harada K, Kono N et al (2002) Damaged interlobular bile ducts in primary biliary cirrhosis show reduced expression of glutathione-S-transferase-pi and aberrant expression of 4-hydroxynonenal. J Hepatol 37:176-183
52. Folci M, Meda F, Gershwin ME, Selmi C (2012) Cutting-edge issues in primary biliary cirrhosis. Clin Rev Allergy Immunol 42:342-354
53. De Santis M, Selmi C (2012) The therapeutic potential of epigenetics in autoimmune diseases. Clin Rev Allergy Immunol 42:92-101
54. Miller FW, Alfredsson L, Costenbader KH et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259-271
55. Miller FW, Pollard KM, Parks CG et al (2012) Criteria for environmentally associated autoimmune diseases. J Autoimmun 39:253-258
56. Selmi C, Gershwin ME (2009) The role of environmental factors in primary biliary cirrhosis. Trends in immunology 30:415-420
57. Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA (2013) The intestinal microbiota in chronic liver disease. Adv Immunol 117:73-97
58. Albano E (2012) Role of adaptive immunity in alcoholic liver disease. Int J Hepatol 2012:893026
59. Selmi C, Lu Q, Humble MC (2012) Heritability versus the role of the environment in autoimmunity. J Autoimmun 39:249-252
60. Tian L, De Hertogh G, Fedeli M et al (2012) Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice. J Autoimmun 38:39-48
61. Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM (2012) Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 38:J109-J119
62. Menon R, Di Dario M, Cordiglieri C et al (2012) Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J Autoimmun 38:J144-J155
63. Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38:J156-J169